SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000912057-02-024121
Filing Date
2002-06-13
Accepted
2002-06-13 16:58:30
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D a2082250zsc13d.htm SC 13D 94656
3 EX-1 a2082250zex-1.htm EX-1 6841
4 EX-2 a2082250zex-2.htm EX-2 146789
  Complete submission text file 0000912057-02-024121.txt   250741
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121 8584537200
ARENA PHARMACEUTICALS INC (Subject) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-59397 | Film No.: 02678526
SIC: 8731 Services-Commercial Physical & Biological Research